MBD2 serves as a viable target against pulmonary fibrosis by inhibiting macrophage M2 program.
Sci Adv. 2021 Jan 1;7(1):eabb6075. doi: 10.1126/sciadv.abb6075. Print 2021 Jan.
Sci Adv. 2021.
PMID: 33277324
Free PMC article.